PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Unprecedented structural insights: NMDA receptors can be blocked to limit neurotoxicity

2014-01-23
(Press-News.org) Contact information: Peter Tarr
tarr@cshl.edu
516-367-8455
Cold Spring Harbor Laboratory
Unprecedented structural insights: NMDA receptors can be blocked to limit neurotoxicity

Cold Spring Harbor, NY – Structural biologists at Cold Spring Harbor Laboratory (CSHL) and collaborators at Emory University have obtained important scientific results likely to advance efforts to develop new drugs targeting NMDA receptors in the brain.

NMDA (N-methyl D-aspartate) receptors are found on the surface of many nerve cells and are involved in signaling that is essential in basic brain functions including learning and memory formation. Problems with their function have been implicated in depression, schizophrenia, Alzheimer's and Parkinson's diseases, as well as brain damage caused by stroke.

Normally, NMDA receptors are activated by glutamate, the most common neurotransmitter of excitatory cell-to-cell messages in the brain.

Overactivation of NMDA receptors is a known cause of nerve-cell toxicity. Thus, drug developers have long sought compounds that can selectively block or antagonize NMDA receptors, while not affecting other types of glutamate receptors in the brain, whose function is essential. However, a basic question -- how those compounds bind and antagonize NMDA receptors -- has not been understood at the molecular level.

Over a period of years, CSHL Associate Professor Hiro Furukawa and colleagues have taken a step-by-step approach to learn about the precise shape of various subunits of the complex NMDA receptor protein, and demonstrating the relationship between different versions of the receptor's shape and its function. (see more here) Since the subunits have different biological roles, they have to be specifically targeted by drug compounds to obtain specific effects.

Furukawa's team has used a technique called x-ray crystallography to map various domains of the protein while it is bound to different chemical compounds, or antagonists, that downregulate its function. Today in the journal Neuron they publish the first crystal structures of two NMDA receptor subunits (called GluN1 and GluN2A) in complex with four different compounds known to have the capacity to inhibit, or antagonize, NMDA receptor function.

Showing this two-unit ligand binding domain (LBD) in complex with NMDA antagonists -- potential drugs -- reveals that each antagonist has a distinctive mode of binding the LBD. In essence, the "docking port" is held open, but to a different extent when different antagonists are bound. The study also reveals an element in the antagonist binding site that is only present in GluN2A subunit, but not in the others. This previously hidden information, says Furukawa, is critical: "It indicates different strategies to develop therapeutic compounds – ones that bind to a certain type of NMDA receptors very specifically. Being able to target specific subtypes of the receptor is of enormous interest and has great therapeutic potential in a range of illnesses and injuries affecting the brain."



INFORMATION:

This research was supported by grants from the National Institutes of Health, the Robertson Research Fund of Cold Spring Harbor Laboratory and Japan Promotion of Science.

About Cold Spring Harbor Laboratory

Founded in 1890, Cold Spring Harbor Laboratory (CSHL) has shaped contemporary biomedical research and education with programs in cancer, neuroscience, plant biology and quantitative biology. CSHL is ranked number one in the world by Thomson Reuters for the impact of its research in molecular biology and genetics. The Laboratory has been home to eight Nobel Prize winners. Today, CSHL's multidisciplinary scientific community is more than 600 researchers and technicians strong and its Meetings & Courses program hosts more than 12,000 scientists from around the world each year. For more information, visit http://www.cshl.edu.



ELSE PRESS RELEASES FROM THIS DATE:

Better protein capture a boon for drug manufacturers

2014-01-23
Rice University scientists have created a way to fine tune a process critical to the pharmaceutical industry that could save a lot of time ...

Spider silk ties scientists up in knots

2014-01-23
Two years ago, researchers from Iowa State University (USA) published a study which concluded that spider silk conducts heat as well as metals. Now, a team from the University of the Basque ...

Can personalized tumor vaccines improve interleukin-2 treated metastatic melanoma?

2014-01-23
New Rochelle, NY, January 22, 2014—Metastatic melanoma has a poor prognosis, but treatment with high-dose interleukin-2 (IL2) can extend survival. Now, ...

Galaxies on FIRE: Star feedback results in less massive galaxies

2014-01-23
For decades, astrophysicists have encountered a puzzling contradiction: although many galactic-wind models—simulations of how matter is distributed in our universe—predict that the majority of ...

Cooling microprocessors with carbon nanotubes

2014-01-23
"Cool it!" That's a prime directive for microprocessor chips and a promising new solution to meeting this imperative is in the ...

UofL epidemiologist uncovers new genes linked to abdominal fat

2014-01-23
LOUISVILLE, Ky. – Excess abdominal fat can be a precursor to diseases such as cardiovascular disease, type 2 diabetes and cancer. A person's measure of belly fat is reflected in the ratio ...

Humans can use smell to detect levels of dietary fat

2014-01-23
PHILADELPHIA (January 22, 2014) – New research from the Monell Center reveals humans can use the sense of smell to detect dietary fat in food. As food smell almost always is detected before taste, the findings ...

'Watch' cites concern about femoral neck fractures in long-necked modular implants

2014-01-23
Needham, MA.–JBJS Case Connector, an online case report journal published by The Journal of Bone and Joint Surgery, has issued ...

Vulvar condition causing painful sex strikes twice as many Hispanic women

2014-01-23
ANN ARBOR, Mich. — ...

Drug discovery potential of natural microbial genomes

2014-01-23
Scientists at the University of California, San Diego have developed a new genetic platform that allows efficient production of naturally ...

LAST 30 PRESS RELEASES:

Participation of women in cardiovascular trials from 2017 to 2023

Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction

Changes in biology of internal fat may be the leading cause of heart failure

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine

High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

New DNA test reveals plants’ hidden climate role

Retinitis pigmentosa mouse models reflect pathobiology of human RP59

Cell’s ‘antenna’ could be key to curing diseases

Tiny ocean partnership between algae and bacteria reveals secrets of evolution

[Press-News.org] Unprecedented structural insights: NMDA receptors can be blocked to limit neurotoxicity